Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-19,518
Closed -$96K – 703
2016
Q4
$96K Sell
19,518
-56
-0.3% -$302 0.01% 690
2016
Q3
$120K Sell
19,574
-43
-0.2% -$257 0.01% 656
2016
Q2
$116K Sell
19,617
-6,806
-26% -$36.5K 0.01% 648
2016
Q1
$137K Buy
+26,423
New +$122K 0.01% 625

Other funds holding ABEV

Raymond James Trust's ABEV Position: Q1 2017 in Review

Raymond James Trust sold out of Ambev (ABEV) in Q1 2017, closing a stake of 19,518 shares — an estimated $96K sold.

Raymond James Trust first reported a position in ABEV in Q1 2016 and held it in 4 quarters. The position peaked at $137K in Q1 2016. 293 funds tracked by Wall St. Rank hold ABEV as of Q1 2017.

  • Raymond James Trust reported no remaining Ambev position as of Q1 2017 after selling out during the quarter.
  • Raymond James Trust sold 19,518 Ambev shares in Q1 2017, an estimated $96K.
  • Raymond James Trust first reported a position in Ambev in Q1 2016 and held it in 4 quarters.
  • Raymond James Trust's Ambev position peaked at $137K in Q1 2016.
  • 293 funds tracked by Wall St. Rank held Ambev as of Q1 2017.

Based on Raymond James Trust's 13F filing for Q1 2017, filed 7 Apr 2017.